The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer
Abstract CINSARC, a multigene expression signature originally developed in sarcomas, was shown to have prognostic impact in various cancers. We tested the prognostic value for disease-free survival (DFS) of CINSARC in a series of 6035 early-stage invasive primary breast cancers. CINSARC had independ...
| 发表在: | npj Breast Cancer |
|---|---|
| Main Authors: | , , , |
| 格式: | 文件 |
| 语言: | 英语 |
| 出版: |
Nature Portfolio
2021-05-01
|
| 在线阅读: | https://doi.org/10.1038/s41523-021-00256-2 |